AKT1 and pancreatic neoplasm: For pathway enrichment, DCBLD2 was mainly associated with PI3K-AKT signaling pathway, Hippo signaling pathway, Rap1 signaling pathway and pancreatic cancer in both cohorts (Figures 7C,D).